Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1995

Primary Completion Date

June 30, 2000

Study Completion Date

June 30, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

asparaginase

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

daunorubicin hydrochloride

DRUG

dexamethasone

DRUG

etoposide

DRUG

leucovorin calcium

DRUG

mesna

DRUG

methotrexate

DRUG

vincristine sulfate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002691 - Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter